PROCÉDÉ ET COMPOSITION PHARMACEUTIQUE POUR INHIBER LA VOIE DE SIGNALISATION PI3K/AKT/MTOR

• 收藏
• 分享

专利权人:

Targeted Therapeutics; LLC

发明人:

申请号：

EP13841191.3

公开号：

EP2905032B1

申请日:

2013.09.29

申请国别(地区):

EP

年份:

2018

代理人:

摘要：

The present invention relates to a pharmaceutical composition of PRCP antagonist, PREP antagonist, or PRCP-PREP dual antagonist. The present invention also relates to a pharmaceutical composition jointly using PRCP antagonist and mTOR antagonist, or jointly using PREP antagonist and mTOR antagonist, or jointly using PRCP-PREP dual antagonist and mTOR antagonist. In addition, the present invention also relates to a method for utilizing the pharmaceutical compositions to treat and prevent cancers and diseases related to insulin receptor substrate protein and PI3K/AKT/mTOR signal pathway.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/